MarketFriction

Evoq Remedies Ltd

BSE 543500 · Trading & Distributors
₹1.52 -0.65%
BSE close2026-10-01
Market cap₹3.81 Cr.

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Standalone, Rs crore
Mar 2021Sep 2021Mar 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Revenue from operations2.764.9311.8515.794.603.900.150.0011.7625.510.00
Operating costs1.714.2011.1215.488.643.831.871.6312.3626.460.50
EBITDA1.050.730.730.31-4.040.07-1.72-1.63-0.60-0.95-0.50
EBITDA margin %38.04%14.81%6.16%1.96%-87.83%1.79%-1,146.67%-5.10%-3.72%
Depreciation & amortisation0.000.000.000.000.000.000.000.000.040.030.02
Finance costs0.000.000.000.000.000.000.000.000.000.000.00
Non-operating income0.000.000.000.006.020.002.260.012.401.060.19
Pre-tax profit1.050.730.730.311.980.070.54-1.621.760.08-0.33
Effective tax rate %22.86%0.00%50.68%0.00%33.84%28.57%29.63%0.00%2.27%25.00%-12.12%
Profit after tax0.810.730.360.311.310.050.38-1.621.710.05-0.29
Earnings per share (Rs)810.00730.000.260.230.960.040.28-0.650.690.02-0.12
Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue from operations3.259.0710.0216.7820.394.0511.7625.51
Operating costs3.239.079.0715.3224.125.6913.9926.96
EBITDA0.020.000.951.46-3.73-1.64-2.23-1.45
EBITDA margin %0.62%0.00%9.48%8.70%-18.29%-40.49%-18.96%-5.68%
Depreciation & amortisation0.000.000.000.000.000.010.050.05
Finance costs0.000.000.000.000.000.000.000.00
Non-operating income0.000.000.000.006.022.262.411.25
Pre-tax profit0.020.000.951.462.290.610.13-0.25
Effective tax rate %0.00%25.26%25.34%29.26%26.23%30.77%-4.00%
Profit after tax0.010.000.721.091.620.450.09-0.24
Earnings per share (Rs)10.000.00720.000.801.190.330.04-0.10
Paid out as dividend %0.00%0.00%0.00%0.00%0.00%0.00%0.00%
10 Years5 Years3 YearsTTM1 YearLast Year
Revenue CAGR%21%8%117%
Profit CAGR%%%-367%
Share price CAGR%%-52%-63%
Average return on equity%2%0%-1%
Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Net block (property, plant)0.000.000.000.000.010.010.220.17
Capital work in progress0.000.000.000.000.000.000.000.00
Investments0.000.000.000.000.000.000.000.00
Current & other assets2.145.658.0433.3334.8936.8649.7951.77
Total assets2.145.658.0433.3334.9036.8750.0151.94
Share capital0.010.010.0113.6013.6013.6024.9024.90
Reserves & surplus0.010.010.739.5711.1911.6419.6419.40
Total debt0.000.010.008.169.584.240.000.07
Other liabilities & provisions2.125.627.302.000.537.395.477.57
Equity + liabilities2.145.658.0433.3334.9036.8750.0151.94
Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating cash flow0.01-0.020.03-26.43-4.355.32-14.62-0.28
Investing cash flow0.000.000.000.00-0.01-0.01-0.260.00
Free cash flow (after capex)0.01-0.020.03-26.43-4.365.31-14.88-0.28
Financing cash flow0.000.000.0029.491.42-5.3414.970.07
Net change in cash0.01-0.020.033.06-2.94-0.030.09-0.21
Cash conversion (OCF / EBITDA) %50%3%-1,785%99%-334%654%19%
Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Return on capital employed %0.00%246.75%9.11%6.97%1.91%0.35%-0.56%
Receivable days138.14189.94249.16552.50308.25156.81267.5455.09
Inventory days3.392.426.9720.6638.33732.3461.9023.92
Payable days239.57226.66315.2532.05-10.20767.4497.5910.89
Cash cycle (days)-98.04-34.30-59.11541.11356.78121.72231.8568.12
Working capital days1.121.2126.23436.56440.902,263.001,369.06631.27
Mar 2022Sep 2022Mar 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Sep 2025Mar 2026
Promoter group %73.53%73.53%73.53%73.53%20.53%11.21%11.21%11.21%11.21%0.02%
Retail & others %26.47%26.48%26.47%26.47%79.47%88.79%88.79%88.78%88.79%99.98%
Shareholder count8247277077271,6721,5881,5771,7231,6791,655

Fundamentals

Market value₹ 3.81 Cr.
Last price₹ 1.53
Book value / share₹ 17.8
Return on capital-0.56 %
Return on equity-0.54 %
Dividend yield0.00 %
Face value₹ 10.0
Revenue CAGR (TTM)117%
Profit CAGR (TTM)-367%
Standalone figures.
Valuation
Market capRs 2 Cr
Enterprise valueRs 6 Cr
P/E (TTM)4.59x
Price to book0.08x
Price to sales0.51x
EV / EBITDA9.98x
EV / EBIT10.14x
EV / sales1.53x
Price to cash flow0.39x
Earnings yield21.77%
P/E, 3-year average21.77x
P/B, 3-year average0.84x
P/E, 5-year average21.77x
P/B, 5-year average0.84x
Profitability
Operating margin (excl. other income)-40.49%
Operating margin (incl. other income)15.31%
EBITDA margin15.31%
Pre-tax margin15.06%
Net profit margin11.11%
ROE1.80%
ROCE1.91%
ROA1.25%
ROE, 3-year average5.89%
ROCE, 3-year average6.00%
ROA, 3-year average3.76%
ROE, 5-year average51.79%
ROCE, 5-year average66.19%
ROA, 5-year average5.45%
ROIC (approx.)1.53%
Tax rate26.23%
Other income / net worth8.95%
Growth
Sales growth (latest year)-80.14%
Profit growth (latest year)-72.22%
Sales CAGR, 3 years-26.06%
Sales CAGR, 5 years4.50%
Profit CAGR, 3 years-14.50%
Profit CAGR, 5 years114.11%
Per share
EPS (TTM)Rs 0.33
EPS (latest year)Rs 0.33
EPS, 3-year averageRs 0.77
EPS, 5-year averageRs 180.58
Book value per shareRs 18.56
Sales per shareRs 2.98
Cash flow per shareRs 3.91
Efficiency
Asset turnover0.11x
Fixed asset turnover405.00x
Inventory turnover0.50x
Inventory days723 days
Debtor days157 days
Debtors turnover2.33x
Leverage
Total debtRs 4 Cr
Cash and bankRs 0 Cr
Net debtRs 4 Cr
Debt to equity0.17x
Net debt / EBITDA6.65x
Owners' fund to total sources68.46%
Debt to assets11.50%
Cash flow
Operating cash flow (latest year)Rs 5 Cr
Investing cash flow (latest year)Rs -0 Cr
Financing cash flow (latest year)Rs -5 Cr
Net change in cash (latest year)Rs -0 Cr
Sales to cash flow0.76x
Statement figures
Net sales (TTM)Rs 4 Cr
Net sales (latest year)Rs 4 Cr
Operating profit excl. other income (latest year)Rs -2 Cr
Other income (TTM)Rs 2 Cr
EBITDA (TTM)Rs 1 Cr
PBDT (TTM)Rs 1 Cr
Profit before tax (TTM)Rs 1 Cr
Tax (latest year)Rs 0 Cr
Net profit (TTM)Rs 0 Cr
Net profit (latest year)Rs 0 Cr
Depreciation (TTM)Rs 0 Cr
Cost of goods sold (latest year)Rs 2 Cr
Total expenditure (latest year)Rs 6 Cr
Total income (latest year)Rs 6 Cr
Share capitalRs 14 Cr
ReservesRs 12 Cr
Shareholders' fundsRs 25 Cr
Total assetsRs 37 Cr
Net blockRs 0 Cr
ReceivablesRs 2 Cr
InventoryRs 3 Cr
Other liabilitiesRs 7 Cr
Shares outstanding (crore)1.36
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/E 4.6 is at the 37th percentile of its own 3.4-year range (median 7.7, low 1.9, high 29.8).
P/B 0.08 is the lowest in 3.4 years (median 0.30).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
Period543500Nifty 50Difference
1 week+8.6%-2.8% +11.4 pts
1 month-10.6%-6.8% -3.8 pts
3 months-37.7%-7.6% -30.1 pts
3 years-89.1%+14.2% -103.3 pts

Red flags

F-score 5 of 8
explainWeak cash conversion Cash from operations was -806% of net profit over the last 3 years
lookInventory outrunning sales Inventory grew 54% vs sales -80% in 2026
lookProfit leans on other income Other income was 370% of pre-tax profit in 2026
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Mar 2026
Sales ₹0 Cr -100.0% vs Mar 2024. Net loss ₹0 Cr.

Activity

Compare
CompanyMcap (Cr)P/EROCE
Redington Ltd31,69717.618.4 %
MMTC Ltd8,51442.38.67 %
MSTC Ltd5,02821.530.3 %
BN Agrochem Ltd1,8981114.44 %
Creative Newtech Ltd1,64622.318.8 %
Pervasive Commodities Ltd1,04922.1 %
RRP Defense Ltd843-11.1 %
Yamuna Syndicate Ltd7848.564.17 %
Shiv Aum Steels Ltd74277.98.20 %
State Trading Corporation of India Ltd64413.3%
Arvaya Healthcare Ltd600451%
SMT Engineering Ltd59624.325.4 %
HP Telecom India Ltd52820.719.9 %
Riddhi Siddhi Gluco Biols Ltd52737.22.74 %
Oswal Agro Mills Ltd4742.03 %
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.

Quick answers

What is the market cap of Evoq Remedies Ltd?

Evoq Remedies Ltd (543500) has a market capitalisation of Rs 3.81 Cr. at the 2026-10-01 close.

What were Evoq Remedies Ltd's latest quarterly results?

In the Mar 2026 quarter, Evoq Remedies Ltd sales was Rs 0 Cr (-100.0% vs Mar 2024) with a net loss of Rs 0 Cr.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03